EpiVax lanza modelos mejorados con IA para la predicción de la inmunogenicidad
<p>PROVIDENCE, R.I., 3 de septiembre de 2026 /PRNewswire/ -- EpiVax, Inc. se complace en anunciar el lanzamiento de mejoras basadas en inteligencia artificial para ISPRI™, su plataforma in silico patentada para evaluar el riesgo de inmunogenicidad de los biofármacos. Esta versión incluye un...</p>
Read original article ↗
Related Articles
Havoc and Rune Technologies Announce Integration to Deliver Autonomous Logistics at the Edge
Integration aimed at giving warfighters contested logistics capability in the world's most dangerous operating environme
What’s in the September Issue?
Each issue of Semiconductor Digest has articles found only in the magazine. Click on the links to read the articles in t
Today, I’m talking with Tom Conrad, the CEO of Sonos. Tom and I have known each other for a long time — he was the chief
New integrations give Grok and Grok Bot users direct access to turn ideas into businesses and let Cursor developers dire